|
RIOK2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.56779999999479E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.70229999985061E-07 |
| Normal-vs-Stage2 |
7.841700E-02 |
| Normal-vs-Stage3 |
5.530300E-02 |
| Normal-vs-Stage4 |
4.501600E-01 |
| Stage1-vs-Stage2 |
2.473800E-01 |
| Stage1-vs-Stage3 |
1.188420E-02 |
| Stage1-vs-Stage4 |
1.389840E-04 |
| Stage2-vs-Stage3 |
5.928600E-01 |
| Stage2-vs-Stage4 |
2.092000E-01 |
| Stage3-vs-Stage4 |
2.787400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.15959999999571E-05 |
| Normal-vs-AfricanAmerican |
3.414000E-01 |
| Normal-vs-Asian |
8.414000E-01 |
| Caucasian-vs-AfricanAmerican |
1.057770E-01 |
| Caucasian-vs-Asian |
4.229600E-01 |
| AfricanAmerican-vs-Asian |
8.616800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.572400E-04 |
| Normal-vs-Female |
3.819400E-04 |
| Male-vs-Female |
6.422000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.862800E-01 |
| Normal-vs-Age(41-60Yrs) |
5.955300E-04 |
| Normal-vs-Age(61-80Yrs) |
5.91770000000214E-05 |
| Normal-vs-Age(81-100Yrs) |
1.742770E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.167020E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.920500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.455000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.200400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.920200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.216200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.984000E-03 |
| Normal-vs-Grade 2 |
4.51910000531797E-08 |
| Normal-vs-Grade 3 |
6.559300E-03 |
| Normal-vs-Grade 4 |
6.234800E-01 |
| Grade 1-vs-Grade 2 |
6.895200E-01 |
| Grade 1-vs-Grade 3 |
4.126000E-01 |
| Grade 1-vs-Grade 4 |
2.300500E-02 |
| Grade 2-vs-Grade 3 |
3.781100E-03 |
| Grade 2-vs-Grade 4 |
3.71880000016311E-07 |
| Grade 3-vs-Grade 4 |
9.959700E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.21099796857038E-11 |
| Normal-vs-ccB subtype |
3.100600E-01 |
| ccA subtype-vs-ccB subtype |
3.03610003804522E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.440700E-04 |
| Normal-vs-N1 |
2.969200E-01 |
| N0-vs-N1 |
2.795700E-02 |
|
|
